Update on invasive opportunistic mycoses: Clinical trials review, 2008–2009 Andreas H. Groll OriginalPaper 06 November 2009 Pages: 417 - 419
Risk-based antifungal prophylaxis in hematologic malignancy and stem cell transplantation Joshua WolfMonica A. Slavin OriginalPaper 06 November 2009 Pages: 420 - 426
Prophylaxis of invasive mycoses in solid organ transplantation Kyle P. RadackBarbara D. Alexander OriginalPaper 06 November 2009 Pages: 427 - 434
New immunosuppressive agents and risk for invasive fungal infections Georg MaschmeyerThomas F. Patterson OriginalPaper 06 November 2009 Pages: 435 - 438
What is the role of therapeutic drug monitoring in antifungal therapy? Jeannina A. Smith OriginalPaper 06 November 2009 Pages: 439 - 446
Genitourinary manifestations of Epstein-Barr virus infections Randi LeighPaul Nyirjesy OriginalPaper 06 November 2009 Pages: 449 - 456
New concepts in understanding genital herpes Joshua T. SchifferLawrence Corey OriginalPaper 06 November 2009 Pages: 457 - 464
MRSA infection of buttocks, vulva, and genital tract in women Orna ReichmanJack D. Sobel OriginalPaper 06 November 2009 Pages: 465 - 470
Antibiotic consideration in bacterial vaginosis Jack D. Sobel OriginalPaper 06 November 2009 Pages: 471 - 475
HIV and the kidney Leslie A. BruggemanCharles BarkRobert C. Kalayjian OriginalPaper 06 November 2009 Pages: 479 - 485
Update on immune reconstitution inflammatory syndrome: Progress and unanswered questions Colleen F. KelleyWendy S. Armstrong OriginalPaper 06 November 2009 Pages: 486 - 493